Medical Health & Life Science Research News

Research delivers insight into the hepatocellular carcinoma drugs market

The analysts forecast the global hepatocellular carcinoma drugs market to grow at a CAGR of 3.40% during the period 2017-2021.

- Agency -.

Hepatocellular Carcinoma Drugs Market 2017

HCC is the most common form of primary liver cancer in adults and occurs mainly in the patients with underlying liver disease and cirrhosis. The disease originates in the liver unlike the secondary liver cancers which reaches to the liver from other organs of the body.

Currently only two drugs NEXAVAR and STIVARGA are approved for the treatment of the disease.

- Agency -.

Covered in this report 
The report covers the present scenario and the growth prospects of the global hepatocellular carcinoma drugs market for 2017-2021. To calculate the market size, the report considers sales of branded, generic, and off-label drugs in HCC treatment market.

The market is divided into the following segments based on geography: 
• Americas 
• APAC 
• EMEA

Report: www.wiseguyreports.com/sample-requ…-market-2017-2021

The report, Global Hepatocellular Carcinoma Drugs Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years.

The report also includes a discussion of the key vendors operating in this market.

Key vendors 
• Bayer 
• Eli Lilly 
• Johnson and Johnson 
• Pfizer

Other prominent vendors 
• Bristol-Myers Squibb 
• Celgene 
• F. Hoffmann-la Roche 
• Gilead 
• GlaxoSmithKline 
• Merck 
• Novartis 
• Salix Pharmaceuticals 
• Transgene

Market driver 
• Growing cases of hepatitis B and C infections 
• For a full, detailed list, view our report

Market challenge 
• Stringent government regulations and trial failure in the late stage of drug development 
• For a full, detailed list, view our report

Market trend 
• Increase in R&D activities for liver cirrhosis medication 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2021 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space?

Report: www.wiseguyreports.com/enquiry/228…-market-2017-2021

 

Table of Contents –Analysis of Key Points

PART 01: Executive summary 
PART 02: Scope of the report 
PART 03: Research Methodology 
PART 04: Introduction 
PART 05: Market landscape 

• Market size and forecast 
• Five forces analysis 
PART 06: Pipeline landscape 
PART 07: Market segmentation by therapy 
• Chemotherapy 
• Brachytherapy 
• Ablation therapy 
PART 08: Geographical segmentation 
• HCC drugs market in Americas 
• HCC drugs market in EMEA 
• HCC drugs market in APAC 
PART 09: Decision framework 
PART 10: Drivers and challenges 
• Market drivers 
• Market challenges 
PART 11: Market trends 
• Increase in R&D activities for liver cirrhosis medication 
• Rise in awareness 

....Continued

Report: www.wiseguyreports.com/checkout?cu…report_id=2284947 

News From

Wise Guy Reports - Market ResearchWise Guy Reports
Category: Market Research Publishers and RetailersCompany profile: Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available. We also provide COTS (Commercial off the Shelf) business sector reports as custom exploration agreeing your particular needs. Our Market Research Reports and Consulting Services  ...